Multi-marker Approach for Risk Assessment in PAH
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Pulmonary Arterial Hypertension
Related studies linked through entity extraction aliases.
Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso
- Status
- COMPLETED
- Phase
- PHASE1
The PAH Platform for Deep Phenotyping in Korean Subjects
- Status
- UNKNOWN
- Phase
- N/A
4DFlow Magnetic Resonance Imaging in Patients With Pulmonary Hypertension Associated With Congenital Heart Disease
- Status
- COMPLETED
- Phase
- NA
Clinical Study of Inhaled GB002 for Treatment of WHO Group I Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE1
A Study of RVT-1201 in Patients With Pulmonary Arterial Hypertension (ELEVATE 1)
- Status
- TERMINATED
- Phase
- PHASE2
miRNA and Myokines in Patients With PAH
- Status
- WITHDRAWN
- Phase
- NA
Utility of At-home Monitoring of Exercise Capacity by App-based 6-minute Walk Test
- Status
- COMPLETED
- Phase
- NA
A Systematic Review of Factors Associated With Pulmonary Arterial Hypertension in Systemic Sclerosis
- Status
- COMPLETED
- Phase
- N/A
Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH
- Status
- COMPLETED
- Phase
- N/A
Hemodynamic Evaluation of Dose-response and Safety of Dry Powder Inhalation of Treprostinil
- Status
- TERMINATED
- Phase
- PHASE2
Study Performed at Various Medical Centers to Learn More About Survival and Expected Course of Pulmonary Arterial Hypertension, a Type of High Blood Pressure in the Lungs Related to the Narrowing of the Small Blood Vessels in the Lungs
- Status
- COMPLETED
- Phase
- N/A
Repeatability and Sensitivity to Change of Non-invasive Endpoints in PAH
- Status
- UNKNOWN
- Phase
- NA
Reducing Right Ventricular Failure in Pulmonary Arterial Hypertension (RELIEVE-PAH)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Implantable System for Remodulin Post-Approval Study
- Status
- WITHDRAWN
- Phase
- N/A
Volatile Organic Compounds (VOCs) as a Biomarker in Immune-mediated Pulmonary Arterial Hypertension (PAH)
- Status
- UNKNOWN
- Phase
- N/A
Prevalence of the Hyperventilation Syndrome in Pulmonary Arterial Hypertension
- Status
- UNKNOWN
- Phase
- NA
Long-Term, Open Label Extension Study of Pemziviptadil (PB1046) in PAH Subjects Following Completion of Study PB1046-PT-CL-0004
- Status
- TERMINATED
- Phase
- PHASE2
Study to Evaluate Efficacy and Safety of JTT-251 in Participants With Pulmonary Arterial Hypertension
- Status
- WITHDRAWN
- Phase
- PHASE2
Olaparib for PAH: a Multicenter Clinical Trial
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2